| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.035 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |